Evidence map›Paper›PMID 36332968›Full record

ArticleGenome research

Methyl-SNP-seq reveals dual readouts of methylome and variome at molecule resolution while enabling target enrichment.

Bo Yan, Duan Wang, Romualdas Vaisvila, Zhiyi Sun, Laurence Ettwiller

Abstract read
In one paragraph

Article in Genome research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bo YanNew England Biolabs, Incorporated, Ipswich, Massachusetts 01938, USA.ORCID 0000-0003-0188-1113
Duan WangSLC Management, Wellesley Hills, Massachusetts 02481, USA.
Romualdas VaisvilaNew England Biolabs, Incorporated, Ipswich, Massachusetts 01938, USA.
Zhiyi SunNew England Biolabs, Incorporated, Ipswich, Massachusetts 01938, USA.ORCID 0000-0002-6106-5356
Laurence EttwillerNew England Biolabs, Incorporated, Ipswich, Massachusetts 01938, USA.ORCID 0000-0002-3957-6539

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Covalent modifications of genomic DNA are crucial for most organisms to survive. Amplicon-based high-throughput sequencing technologies erase all DNA modifications to retain only sequence information for the four canonical nucleobases, necessitating specialized technologies for ascertaining epigenetic information. To also capture base modification information, we developed Methyl-SNP-seq, a technology that takes advantage of the complementarity of the double helix to extract the methylation and original sequence information from a single DNA molecule. More specifically, Methyl-SNP-seq uses bisulfite conversion of one of the strands to identify cytosine methylation while retaining the original four-bases sequence information on the other strand. As both strands are locked together to link the dual readouts on a single paired-end read, Methyl-SNP-seq allows detecting the methylation status of any DNA even without a reference genome. Because one of the strands retains the original four nucleotide composition, Methyl-SNP-seq can also be used in conjunction with standard sequence-specific probes for targeted enrichment and amplification. We show the usefulness of this technology in a broad spectrum of applications ranging from allele-specific methylation analysis in humans to identification of methyltransferase specificity in complex bacterial communities.

Indexed as

DNA MethylationEpigenomeAllelesDNAHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNASulfitesDNASulfites

Identifiers

PMID36332968
PMCPMC9808626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.